A buffer consisting of Tris, boric acid, and EDTA! A buffer commonly used during electrophoresis.
The "5 x TBE" is a stock solution at a concentration five times the usage conditions. It is a buffer composed of Tris, boric acid, and EDTA, commonly used during electrophoresis, similar to TAE (10 x TAE, 50 x TAE). When used in agarose gel electrophoresis, it can be diluted to "0.5 x TBE" with water at a 10-fold dilution. For polyacrylamide gel electrophoresis, "1 x TBE" is used, diluted 5 times with water. 【Specifications】 ■ Composition: 0.445 mol/l Tris-borate, 10 mmol/l EDTA ■ Dilution Guidelines - Agarose Gel Electrophoresis: 10-fold dilution (Working Solution: 0.5 x TBE) - Polyacrylamide Gel Electrophoresis: 5-fold dilution (Working Solution: 1 x TBE) ■ Storage Method: Room temperature ■ Notes: Confirm that normal electrophoresis can be performed without issues. *For more details, please refer to the related links or feel free to contact us.
Inquire About This Product
basic information
【Product Details】 ■Components: 5 x TBE ■Capacity: 1,000 ml x 1 ■Storage: Room temperature ■Notes: Square plastic bottle (container) *For more details, please refer to the related links or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■ Electrophoresis, preparation of agarose gel, preparation of gel staining solution *For more details, please refer to the related links or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company is a product development-oriented enterprise that utilizes biotechnology. We develop and manufacture in vitro diagnostic pharmaceuticals (such as pregnancy tests and ovulation tests), diagnostic drugs for environmental, food, and animal and plant diseases, and reagents for genetic engineering research, using our expertise in gene and antibody technology. We hold manufacturing registration and manufacturing and sales licenses for both human and animal products, with over 30 years of experience in the manufacture of in vitro diagnostic pharmaceuticals. Additionally, we are engaged in personalized medicine, advancing research and development of diagnostic drugs using genetic polymorphism analysis and gene expression analysis.
